UK markets closed
  • FTSE 100

    6,630.52
    -20.36 (-0.31%)
     
  • FTSE 250

    20,961.31
    -334.92 (-1.57%)
     
  • AIM

    1,163.26
    -10.13 (-0.86%)
     
  • GBP/EUR

    1.1607
    +0.0010 (+0.09%)
     
  • GBP/USD

    1.3834
    -0.0060 (-0.43%)
     
  • BTC-GBP

    35,643.88
    +525.45 (+1.50%)
     
  • CMC Crypto 200

    982.93
    +39.75 (+4.21%)
     
  • S&P 500

    3,841.94
    +73.47 (+1.95%)
     
  • DOW

    31,496.30
    +572.16 (+1.85%)
     
  • CRUDE OIL

    66.28
    +2.45 (+3.84%)
     
  • GOLD FUTURES

    1,698.20
    -2.50 (-0.15%)
     
  • NIKKEI 225

    28,864.32
    -65.78 (-0.23%)
     
  • HANG SENG

    29,098.29
    -138.50 (-0.47%)
     
  • DAX

    13,920.69
    -135.65 (-0.97%)
     
  • CAC 40

    5,782.65
    -48.00 (-0.82%)
     

Polish medical gloves maker Mercator reviews strategic options

·1-min read

WARSAW (Reuters) - Polish medical gloves producer Mercator Medical said late on Wednesday it has started a review of strategic options to increase its production potential.

Shares in Mercator, which is valued at 3.87 billion zlotys ($1.04 billion), jumped to 364 zlotys each at close on Wednesday from 14.7 zlotys a year earlier amid increased demand for medical equipment due to the COVID-19 pandemic.

"As part of the process, management intends to analyse possible development scenarios for the group's production and distribution segments, bearing in mind the long-term goal which is increasing the value of the group," Mercator said.

The group, which makes medical gloves and distributes single-use medical supplies, was founded in 1996. The company is selling to nearly 70 countries and has a 2% share in the global market, according to its website.

(Reporting by Agnieszka Barteczko; Editing by Krishna Chandra Eluri)